Intellectual Property, Patents, Technology Biotech Insights: 2018 industry snapshot and key trends 1 June 2018 By Veg Tran Read on
Intellectual Property, Patents Fast drugs, new drugs: new opportunities in the healthcare industry in Australia and China 27 April 2018 By Suzy Madar Read on
Intellectual Property, Patents Second throw of the dice unsuccessful: Full Federal Court confirms Hepatitis C drug patent is invalid 21 December 2017 By Suzy Madar Read on
Intellectual Property Biosimilars: balancing access to affordable medicines with safety 3 November 2017 By Suzy Madar Read on
Intellectual Property, Patents Here’s the drill: The Full Federal Court clarifies the requirement that patents disclose the ‘best method’ of performing the invention 27 September 2017 By Tim Craven Read on
Intellectual Property, Litigation, Patents Threats Muddy Waters: unjustified threats of infringement in the Full Federal Court of Australia 26 May 2017 By Alex Horne Read on
Intellectual Property, Patents, Technology ‘Essential’ telecom patents: How to win FRANDs and influence people 4 May 2017 By Sarah-Jane Frydman Read on
Intellectual Property, Patents Off to a running start? Federal Court of Australia permits generic manufacturer to make PBS application before patent expiry 28 April 2017 By Kim O'Connell Read on
Intellectual Property, Patents Big data, big risk – investing in a “largely theoretical” industry 24 February 2017 By Priscilla Hejtmanek Read on
Intellectual Property, Patents Don’t you wanna dance with me? US Supreme Court to hear Amgen v Sandoz biosimilars case 24 January 2017 By Alex Horne Read on
